Evelo Biosciences, Inc.

BANK OF AMERICA CORP /DE/ EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

50,825

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	9	0.0%	50,825	3/31/2023
2022 Q4	2/10/2023	31	0.0%	19,279	12/31/2022
2022 Q3	11/14/2022	102	0.0%	48,706	9/30/2022
2022 Q2	8/12/2022	59	0.0%	28,241	6/30/2022
2022 Q1	5/16/2022	55	0.0%	16,165	3/31/2022
2021 Q4	2/8/2022	208	0.0%	34,288	12/31/2021
2021 Q3	11/15/2021	49	0.0%	6,957	9/30/2021
2021 Q2	9/13/2021	91	0.0%	6,636	6/30/2021
2021 Q1	5/14/2021	350	0.0%	32,699	3/31/2021
2020 Q4	2/10/2021	85	0.0%	7,006	12/31/2020
2020 Q3	11/13/2020	23	0.0%	4,308	9/30/2020
2020 Q2	8/14/2020	25	0.0%	5,171	6/30/2020
2020 Q1	5/15/2020	13	0.0%	3,383	3/31/2020
2019 Q4	2/14/2020	30	0.0%	7,422	12/31/2019